We know the pandemic disrupted everything, including how we track and treat other serious diseases. A new report from health officials gives us a look at tuberculosis cases across the entire United States population for the year 2021. The report itself doesn't say whether the number of TB cases increased or decreased from previous years, or what might have driven any change. It's simply a status check, a single point in time. Without that comparison or deeper analysis, we can't draw conclusions about trends or the pandemic's impact. This kind of data is a necessary first step for public health experts to understand where to look next.
U.S. tuberculosis incidence data reported for 2021 in observational analysisWhat happened to tuberculosis rates in the US during the pandemic?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Note: 2021 U.S. TB incidence data is observational; detailed rates and methods are not reported.
An observational report provided data on tuberculosis incidence within the United States population for the year 2021. The analysis did not specify a sample size, a particular intervention or exposure, or a comparator group. The primary outcome was the incidence of tuberculosis, but the exact rate, effect size, absolute numbers, and statistical measures were not reported in the provided data.
No information on safety, adverse events, or tolerability was available from this report. The funding sources and potential conflicts of interest were also not reported.
Key limitations include the lack of detailed methodological reporting, such as sample size and specific incidence figures. The absence of a comparator or intervention analysis restricts causal inference. For clinical practice, this report serves as a basic surveillance update; clinicians should refer to official public health sources like the CDC for complete annual tuberculosis statistics and trends.
What this means for you:
A 2021 snapshot of US TB cases is in, but trends and causes are unclear. More on Tuberculosis
Video observed therapy improves treatment success and adherence in adults with tuberculosis
Digital Tools Show Better Success Rates for Tuberculosis Treatment
This network meta-analysis of 29 randomized controlled trials evaluated digital health interventions for tuberculosis. Video observed therap…
Video observed therapy shows higher success and adherence rates for patients with tuberculosis compared to traditional face-to-face methods.
Water buffalo act as reservoirs for infectious diseases in mixed livestock systems
Water Buffalo May Spread Diseases to Other Livestock
This systematic review analyzes 180 articles regarding infectious diseases in water buffalo. The authors conclude that these animals are inc…
A review of 180 articles suggests water buffalo act as disease reservoirs, meaning they can pass infections to other animals in mixed farmin…
HIV linked to lower odds of post-TB lung disease; undernutrition raises risk
Undernutrition and HIV may lower or raise lung damage risk after tuberculosis in low-income nations
This systematic review and meta-analysis of 41 studies in LMICs found that HIV was associated with reduced odds of spirometry-defined post-t…
New analysis of data from low-income countries shows mixed results on how HIV, diabetes, and poor nutrition affect lung health after tubercu…
Immediate antituberculosis therapy did not reduce mortality in HIV-related sepsis overall
Immediate TB treatment helps only those with confirmed infection in HIV sepsis
This trial investigated whether starting antituberculosis treatment immediately or using high doses improved survival in adults with HIV-rel…
In HIV sepsis, starting TB drugs immediately did not lower death rates overall, but helped only patients later confirmed to have TB.
View Original Abstract ↓
This report describes tuberculosis incidence in the U.S. during 2021.
Real-world meta-analysis supports pembrolizumab for advanced NSCLC with high PD-L1
Real-world data confirms pembrolizumab offers long-term survival for advanced lung cancer patients
Related in Pulmonology & Critical Care
FDA Approves Provocholine (methacholine chloride) for Bronchial Airway Hyperreactivity Diagnosis
FDA approves new test to help diagnose asthma in certain patients
The FDA approved Provocholine (methacholine chloride) for diagnosing bronchial airway hyperreactivity in adults and children aged 5 years an…
The FDA approved Provocholine, a drug used in a breathing test to diagnose airway hyperreactivity in people aged 5 and older who may have as…
Tislelizumab plus chemotherapy improves survival in extensive-stage small cell lung cancer
Immunotherapy combo extends survival in small cell lung cancer
This phase 3 RCT evaluated tislelizumab plus chemotherapy versus placebo plus chemotherapy in previously untreated extensive-stage small cel…
Adding tislelizumab to chemo helped people with extensive-stage small cell lung cancer live 2 months longer, a phase 3 trial shows.
Lower PEEP may increase ventilator-free days in ventilated patients without ARDS
Lower breathing pressure settings showed modest benefits for some critically ill patients without lung injury
This Bayesian re-analysis of an RCT in 980 invasively ventilated critically ill patients without ARDS found that lower PEEP (0-5 cm H2O) com…
A re-analysis of data found that using the lowest safe breathing pressure might help some patients breathe easier. However, the overall bene…
Machine learning models show moderate accuracy predicting neoadjuvant immunotherapy response in NSCLC
Machine learning models predict how well lung cancer patients respond to immunotherapy
This systematic review and meta-analysis of 44 models found that machine learning predicts neoadjuvant immunotherapy response in resectable …
A new analysis of 44 models shows computer programs can guess which lung cancer patients will benefit from immunotherapy, though the study h…
From Other Specialties
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …
Rapid advancements in imaging and blood-based biomarkers are transforming the diagnosis and management of ADRD
New guidelines help doctors tell delirium from dementia
This clinical guideline provides a narrative review on the evolving diagnostic and treatment landscape for Alzheimer's disease and related d…
Delirium is acute and fluctuating; dementia is chronic. New guidelines help doctors tell them apart.
ACTH and vigabatrin achieved full seizure control in a patient with Ververi-Brady syndrome
ACTH and Vigabatrin Show Promise for Rare Epilepsy Syndrome
This case report describes a 5-month-old male infant with Ververi-Brady syndrome and infantile epileptic spasms syndrome. The patient achiev…
A new gene variant linked to Ververi-Brady syndrome showed positive results when treated with a combination of ACTH and vigabatrin.